ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
4
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,241
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Phase I trial of 5-azacitidine (5AC) and SNDX-275 in advanced lung cancer (NSCLC)
Author(s):
RA Juergens
,
F. Vendetti
,
B. COLEMAN
,
RS Sebree
,
MA Rudek
,
SA Belinsky
,
MV Brock
,
JG Herman
,
SB Baylin
,
CM Rudin
,
Louis Juergens
,
R. S. Sebree
,
M. A. Rudek
,
Steven A. Belinsky
,
M. Brock
,
J. Herman
,
S. B. Baylin
,
Andrew M. Rudin
,
B Coleman
Publication date:
2008
Journal:
J Clin Oncol
Read this article at
ScienceOpen
Publisher
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Bacterial extracellular vesicles
Author and article information
Journal
DOI::
10.1200/jco.2008.26.15_suppl.19036
ScienceOpen disciplines:
Molecular medicine
Data availability:
ScienceOpen disciplines:
Molecular medicine
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,241
Entinostat (SNDX-275), a novel DAC inhibitor, is highly effective in rituximab-[chemotherapy]-sensitive or rituximab-[chemotherapy]-resistant lymphomas and has synergistic anti-tumor activity when combined with bortezomib
Authors:
U. Ashraf
,
MS Czuczman
,
C Marvis
…
Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction.
Authors:
Natasha Musrap
,
George Karagiannis
,
Punit Saraon
…
HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance.
Authors:
XiaoHe Yang
,
Xiaoping Huang
,
Bolin Liu
…
See all similar
Cited by
4
Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
Authors:
Mario Federico
,
Luigi Bagella
No patient left behind: The promise of immune priming with epigenetic agents
Authors:
Corey Carter
,
Bryan Oronsky
,
Joseph Roswarski
…
Personalized tumor combination therapy optimization using the single-cell transcriptome
Authors:
Chen Tang
,
Shaliu Fu
,
Xuan Jin
…
See all cited by